Cargando…

Mild COVID-19 infection-predicting symptomatic phase and outcome: A study from AIIMS, New Delhi

CONTEXT: Comprehensive management of mild COVID infection calls for better understanding of symptomatology in these group of patients as well as early identification and close monitoring of patients at risk, data on which is limited. AIM: To study association between inflammatory markers and clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirtana, J, Kumar, Arvind, Kumar, Swasthi S., Singh, Anupam K., Shankar, Sujay Halkur, Sharma, Amrit, Kumar, Amit, Kaur, Ravneet, Khan, Maroof A., Ranjan, Piyush, Sethi, Prayas, Chakravarthy, Avinash, Srivastava, Achal K., Wig, Naveet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773059/
https://www.ncbi.nlm.nih.gov/pubmed/33409216
http://dx.doi.org/10.4103/jfmpc.jfmpc_1610_20
_version_ 1783629988581343232
author Kirtana, J
Kumar, Arvind
Kumar, Swasthi S.
Singh, Anupam K.
Shankar, Sujay Halkur
Sharma, Amrit
Kumar, Amit
Kaur, Ravneet
Khan, Maroof A.
Ranjan, Piyush
Sethi, Prayas
Chakravarthy, Avinash
Srivastava, Achal K.
Wig, Naveet
author_facet Kirtana, J
Kumar, Arvind
Kumar, Swasthi S.
Singh, Anupam K.
Shankar, Sujay Halkur
Sharma, Amrit
Kumar, Amit
Kaur, Ravneet
Khan, Maroof A.
Ranjan, Piyush
Sethi, Prayas
Chakravarthy, Avinash
Srivastava, Achal K.
Wig, Naveet
author_sort Kirtana, J
collection PubMed
description CONTEXT: Comprehensive management of mild COVID infection calls for better understanding of symptomatology in these group of patients as well as early identification and close monitoring of patients at risk, data on which is limited. AIM: To study association between inflammatory markers and clinical presentation with progression of disease and the duration of resolution of symptoms. SETTINGS AND DESIGN: This is a retrospective study that has been conducted at a designated COVID -19 medical ward at AIIMS, New Delhi METHODS AND MATERIAL: Fifty healthcare workers and their dependents who were admitted with asymptomatic and mild COVID-19 infection were included. Their records were retrospectively reviewed, entered into a predesigned proforma and analyzed. RESULTS: A total of 50 participants were included in the study of which 70% were healthcare workers. The patients were admitted with mild COVID illness out of which 22 (44%) were males. Most common symptom at presentation was fever (72%). Among patients who had mild disease versus those who progressed to moderate illness (n = 3), the patients with moderate illness were older [mean (SD): 57.33 (10.21) vs. 36.13 (14.05); P = 0.014] and had a longer duration of hospital stay [17 (1.41) days vs. 11.20 (3.86) days; P = 0.04]. Inflammatory markers, C-Reactive Protein (CRP) [2.46 vs. 0.20 (P = 0.024)], and Ferritin [306.15 vs. 72.53 (P = 0.023)] were higher in patients with moderate illness. There is also a significant correlation between the number of days taken for symptoms to resolve with Serum Ferritin (P = 0.007), CRP (P = 0.0256), and neutrophil lymphocyte ratio (NLR) (P = 0.044). CONCLUSIONS: Acute phase reactants/Inflammatory markers serve as good indicators of time taken to resolution of symptoms in acute COVID infection. NLR is a simple and inexpensive method to provide insight into symptomatic phase. These may be utility tools for primary care physician in the management in periphery and timely decision.
format Online
Article
Text
id pubmed-7773059
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-77730592021-01-05 Mild COVID-19 infection-predicting symptomatic phase and outcome: A study from AIIMS, New Delhi Kirtana, J Kumar, Arvind Kumar, Swasthi S. Singh, Anupam K. Shankar, Sujay Halkur Sharma, Amrit Kumar, Amit Kaur, Ravneet Khan, Maroof A. Ranjan, Piyush Sethi, Prayas Chakravarthy, Avinash Srivastava, Achal K. Wig, Naveet J Family Med Prim Care Original Article CONTEXT: Comprehensive management of mild COVID infection calls for better understanding of symptomatology in these group of patients as well as early identification and close monitoring of patients at risk, data on which is limited. AIM: To study association between inflammatory markers and clinical presentation with progression of disease and the duration of resolution of symptoms. SETTINGS AND DESIGN: This is a retrospective study that has been conducted at a designated COVID -19 medical ward at AIIMS, New Delhi METHODS AND MATERIAL: Fifty healthcare workers and their dependents who were admitted with asymptomatic and mild COVID-19 infection were included. Their records were retrospectively reviewed, entered into a predesigned proforma and analyzed. RESULTS: A total of 50 participants were included in the study of which 70% were healthcare workers. The patients were admitted with mild COVID illness out of which 22 (44%) were males. Most common symptom at presentation was fever (72%). Among patients who had mild disease versus those who progressed to moderate illness (n = 3), the patients with moderate illness were older [mean (SD): 57.33 (10.21) vs. 36.13 (14.05); P = 0.014] and had a longer duration of hospital stay [17 (1.41) days vs. 11.20 (3.86) days; P = 0.04]. Inflammatory markers, C-Reactive Protein (CRP) [2.46 vs. 0.20 (P = 0.024)], and Ferritin [306.15 vs. 72.53 (P = 0.023)] were higher in patients with moderate illness. There is also a significant correlation between the number of days taken for symptoms to resolve with Serum Ferritin (P = 0.007), CRP (P = 0.0256), and neutrophil lymphocyte ratio (NLR) (P = 0.044). CONCLUSIONS: Acute phase reactants/Inflammatory markers serve as good indicators of time taken to resolution of symptoms in acute COVID infection. NLR is a simple and inexpensive method to provide insight into symptomatic phase. These may be utility tools for primary care physician in the management in periphery and timely decision. Wolters Kluwer - Medknow 2020-10-05 /pmc/articles/PMC7773059/ /pubmed/33409216 http://dx.doi.org/10.4103/jfmpc.jfmpc_1610_20 Text en Copyright: © 2020 Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Kirtana, J
Kumar, Arvind
Kumar, Swasthi S.
Singh, Anupam K.
Shankar, Sujay Halkur
Sharma, Amrit
Kumar, Amit
Kaur, Ravneet
Khan, Maroof A.
Ranjan, Piyush
Sethi, Prayas
Chakravarthy, Avinash
Srivastava, Achal K.
Wig, Naveet
Mild COVID-19 infection-predicting symptomatic phase and outcome: A study from AIIMS, New Delhi
title Mild COVID-19 infection-predicting symptomatic phase and outcome: A study from AIIMS, New Delhi
title_full Mild COVID-19 infection-predicting symptomatic phase and outcome: A study from AIIMS, New Delhi
title_fullStr Mild COVID-19 infection-predicting symptomatic phase and outcome: A study from AIIMS, New Delhi
title_full_unstemmed Mild COVID-19 infection-predicting symptomatic phase and outcome: A study from AIIMS, New Delhi
title_short Mild COVID-19 infection-predicting symptomatic phase and outcome: A study from AIIMS, New Delhi
title_sort mild covid-19 infection-predicting symptomatic phase and outcome: a study from aiims, new delhi
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773059/
https://www.ncbi.nlm.nih.gov/pubmed/33409216
http://dx.doi.org/10.4103/jfmpc.jfmpc_1610_20
work_keys_str_mv AT kirtanaj mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi
AT kumararvind mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi
AT kumarswasthis mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi
AT singhanupamk mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi
AT shankarsujayhalkur mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi
AT sharmaamrit mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi
AT kumaramit mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi
AT kaurravneet mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi
AT khanmaroofa mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi
AT ranjanpiyush mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi
AT sethiprayas mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi
AT chakravarthyavinash mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi
AT srivastavaachalk mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi
AT wignaveet mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi